A recent study (L Norsa et al. JPGN 2018; 67: 361-6) examines data from 197 patients with celiac disease (CD) (out of a cohort of 337) who had a diagnosis established before 1985. The authors examined three groups: lifelong strict GFD (n=133), discontinued GFD (n=29), and no GFD (22). A total of 63 had follow-up endoscopy data available, with 29 in lifelong GFD, 20 in discontinued GFD, and 14 in no GFD.
Key findings:
- In those with followup endoscopy, in those with lifelong GFD 27 of 29 (93%) had no atrophy (Marsh 0-1-2) on histology, in those with discontinued GFD 12 of 20 (60%) had no atrophy on histology, and in those with no GFD 8 of 14 (57%) had no atrophy on histology.
- Thus, among the group with long-term poor adherence to gluten-free diet, almost two-thirds showed no recurrence of villous atrophy on duodenal biopsies.
- In the entire cohort of 197, there were no apparent differences in autoimmune diseases between those receiving lifelong GFD (26%) compared to the other two groups, 17% and 23% respectively.
Limitations:
- retrospective design.
- initial diagnosis was more than 30 years ago & there are significant differences in the diagnostic approach currently
- sample size
My take: This study indicates that some individuals who have been diagnosed with celiac disease may be OK with ongoing gluten consumption. Those who maintained a GFD were much more likely to have no villous atrophy on duodenal biopsies.
Related blog posts:
- Celiac Disease: “Ten Things That Every Gastroenterologist Should Know”
- Another Look at Gluten-free Diet for Asymptomatic Celiac …
- How Accurate is Serology at Predicting Mucosal Healing in …
- Gluten-Related Disorders” (Part 1) | gutsandgrowth
- Closer followup for Celiac disease & pediatric guidelines …
- Nuance in Celiac Serology Interpretation | gutsandgrowth
- Expert review: Celiac disease | gutsandgrowth
- What is Gluten-Free? | gutsandgrowth
- Good Educational Two Minute Celiac Video | gutsandgrowth
